Effects of exercise training programs on physical performance and quality of life in patients with metastatic lung cancer undergoing palliative chemotherapy-A study protocol

Contemporary Clinical Trials

Volumn 37, Issue 1, 2014, Pages 120-128

  Jensen, Wiebke ^a   Oechsle, Karin ^a   Baumann, Hans Jörg ^a   Mehnert, Anja ^b   Klose, Hans ^a   Bloch, Wilhelm ^c   Bokemeyer, Carsten ^a   Baumann, Freerk T ^c  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^c GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

Author keywords

Aerobic exercise training; Cardio respiratory fitness; Lung cancer; Palliative chemotherapy; Quality of life; Resistance training

Indexed keywords

ADULT; AEROBIC EXERCISE; ARTICLE; ARTIFICIAL VENTILATION; BLOOD PRESSURE MEASUREMENT; BODY COMPOSITION; BODY HEIGHT; BODY MASS; BODY WEIGHT; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CHRONIC INFLAMMATION; CONTROLLED STUDY; EXERCISE; GLUCOSE METABOLISM; HUMAN; LIPID METABOLISM; LUNG FUNCTION; LUNG METASTASIS; MUSCLE STRENGTH; OVERALL SURVIVAL; OXYGEN CONSUMPTION; PHYSICAL ACTIVITY; PHYSICAL PERFORMANCE; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RESISTANCE TRAINING; RESTING HEART RATE; TRAINING;

AEROBIC EXERCISE TRAINING; CARDIO-RESPIRATORY FITNESS; LUNG CANCER; PALLIATIVE CHEMOTHERAPY; QUALITY OF LIFE; RESISTANCE TRAINING;

EXERCISE; EXERCISE THERAPY; FEMALE; HUMANS; KARNOFSKY PERFORMANCE STATUS; LUNG NEOPLASMS; MALE; OXYGEN CONSUMPTION; PALLIATIVE CARE; PHYSICAL FITNESS; QUALITY OF LIFE; RESISTANCE TRAINING;

EID: 84890842633     PISSN: 15517144     EISSN: 15592030     Source Type: Journal    
DOI: 10.1016/j.cct.2013.11.013     Document Type: Article

References (60)

1. Berglund G., Bolund C., Gustafsson U.L., Sjödén P.O. One-year follow up of the "Starting Again" group rehabilitation programme for cancer patients. Eur J Cancer 1994, 30:1744-1751.
2. Courneya K.S., Mackey J.R., Bell G.J., Jones L.W., Field C.J., Fairey A.S. Randomized controlled trial of exercise training in postmenopausal breast cancer survivors. J Clin Oncol 2003, 21:1660-1668.
3. Pinto B., Clark M., Maruyama N., Feder S.I. Psychological and fitness changes associated with exercise participation among women with breast cancer. Psychooncology 2003, 12:118-126.
4. Dimeo F., Fetscher S., Lange W., Mertelsmann R., Keul J. Effects of aerobic exercise on the physical performance and incidence of treatment-related complications after high-dose chemotherapy. Blood 1997, 90:3390-3394.
5. Dimeo F., Stieglitz R., Novelli-Fischer U., Fetscher S., Keul J. Effects of physical activity on the fatigue and psychologic status of cancer patients during chemotherapy. Cancer 1999, 85:2273-2277.
6. Knols R., Aaronson N.K., Uebelhardt D., Fransen J., Aufdemkampe G. Physical excercise in cancer patients during and after medical treatment: a systematic review of randomized and controlled trials. J Clin Oncol 2005, 23:3830-3842.
7. Mello M., Tanaka C., Dulley F. Effects of an exercise program on muscle performance in patients undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant 2003, 32:723-728.
8. Fair A.M., Dai Q., Shu X.O., Matthews C.E., Yu H., Jin F., et al. Energy balance, insulin resistance biomarkers, and breast cancer risk. Cancer Detect Prev 2007, 31:214-219.
9. Fairey A.S., Courneya K.S., Field C.J., Bell G.J., Jones L.W., Mackey J.R. Randomized controlled trial of exercise and blood immune function in postmenopausal breast cancer survivors. J Appl Physiol 2005, 98:1534-1540.
10. Fairey A.S., Courneya K.S., Field C.J., Bell G.J., Jones L.W., Mackey J.R. Effects of exercise training on fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast cancer survivors: a randomized controlled trial. Cancer Epidemiol Biomarkers Prev 2003, 12:721-727.
11. Ligibel J.A., Campbell N., Partridge A., Chen W.Y., Salinardi T., Chen H., et al. Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors. J Clin Oncol 2008, 26:907-912.
12. Erlinger T.P., Platz E.A., Rifai N., Helzlsouer K.J. C-reactive protein and the risk of incident colorectal cancer. JAMA 2004, 291:585-590.
13. Strange K.S., Wilkinson D., Edin G., Emerman J.T. Mitogenic properties of insulin-like growth factors I and II, insulin-like growth factor binding protein-3 and epidermal growth factor on human breast stromal cells in primary culture. Breast Cancer Res Treat 2004, 84:77-84.
14. Fairey A.S., Courneya K.S., Field C.J., Field C.J., Bell G.J., Jones L.W., et al. Effect of exercise training on C-reactive protein in postmenopausal breast cancer survivors: a randomized controlled trial. Brain Behav Immun 2005, 19:381-388.
15. Hojman P., Dethlefsen C., Brandt C., Hansen J., Pedersen L., Pedersen B.K. Exercise-induced muscle-derived cytokines inhibit mammary cancer cell growth. Am J Physiol Endocrinol Metab 2011, 301:E504-E510.
16. Jones L.W., Viglianti B.L., Tashjian J.A., Kothadia S.M., Keir S.T., Freedland S.J., et al. Effect of aerobic exercise on tumor physiology in an animal model of human breast cancer. J Appl Physiol 2010, 108:343-348.
17. Jones L.W., Fels D.R., West M., Allen J.D., Broadwater G., Barry W.T., et al. Modulation of circulating angiogenic factors and tumor biology by aerobic training in breast cancer patients receiving neoadjuvant chemotherapy. Cancer Prev Res 2013, 6:925-937.
18. Lowe S.S., Watanabe S.M., Courneya K.S. Physical activity as a supportive care intervention in palliative cancer patients: a systematic review. J Support Oncol 2009, 7:27-34.
19. Lowe S.S., Watanabe S.M., Baracos V.E., Courneya K.S. Associations between physical activity and quality of life in cancer patients receiving palliative care: a pilot survey. J Pain Symptom Manage 2009, 38:785-796.
20. Lowe S.S., Watanabe S.M., Baracos V.E., Courneya K.S. Physical activity interests and preferences in palliative cancer patients. Support Care Cancer 2010, 18:1469-1475.
21. Joly F., Vardy J., Pintilie M., Tannrock I.F. Quality of life and/or symptom control in randomized clinical trials for patients with advanced cancer. Ann Oncol 2007, 18:1935-1942.
22. Hopwood P., Stephens R.J. Depression in patients with lung cancer: prevalence and risk factors derived from quality-of life data. J Clin Oncol 2000, 18:893-903.
23. Lutz S., Norrell R., Bertucio C., Kachnic L., Johnson C., Arthur D., et al. Symptom frequency and severity in patients with metastatic or locally recurrent lung cancer: a prospective study using the Lung Cancer Symptom Scale in a community hospital. J Palliat Med 2001, 4:157.
24. Brown D.J., McMillan D.C., Milroy R. The correlation between fatigue, physical function, the systemic inflammatory response, and psychological distress in patients with advanced lung cancer. Cancer 2005, 103:377-382.
25. Simon G.R., Turrisi A.T. III Management of small cell lung cancer. ACCP evidence-based clinical practice guidelines. Chest 2007, 132:324S-339S.
26. Scagliotti G.V., Parikh P., von Pawel J., Biesma B., Vansteenkiste J., Manegold C., et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 2008, 26:3543-3551.
27. Granger C.L., McDonald C.F., Berney S., Chao C., Denehy L. Exercise intervention to improve exercise capacity and health related quality of life for patients with non-small cell lung cancer: a systematic review. Lung Cancer 2011, 72:139-153.
28. Jones L.W., Eves N.D., Kraus W.E., Potti A., Crawford J., Blumenthal J.A., et al. The lung cancer exercise training study: a randomized trial of aerobic training, resistance training, or both in postsurgical lung cancer patients: rationale and design. BMC Cancer 2010, 10:155.
29. Rogers E.S., MacLeod R.D., Stewart J., Bird S.P., Keogh J.W. A randomized feasibility study EPA and Cox-2 inhibitor (Celebrex) versus EPA, Cox-2 inhibitor (Celebrex), resistance training followed by ingestion of essential amino acids high in leucine in NSCLC cachectic patients - ACCeRT study. BMC Cancer 2011, 23(11):493.
30. Arbane G., Tropman D., Jackson D., Garrod R. Evaluation of an early exercise intervention after thoracotomy for non-small cell lung cancer (NSCLC), effects on quality of life, muscle strength and exercise tolerance: randomised controlled trial. Lung Cancer 2011, 71:229-234.
31. Maddocks M., Wilcock A. Exploring physical activity level in patients with thoracic cancer: implications for use as an outcome measure. Support Care Cancer 2012, 20:1113-1116.
32. Henke C.C., Cabri J., Fricke L., Pannkow W., Kandilakis G., Feyer P.C., et al. Strength and endurance training in the treatment of lung cancer patients stage IIIA/IIIB/IV. Support Care Cancer 2014, 22:95-101.
33. Adamsen L., Stage M., Laursen J., Rørth M., Quist M. Exercise and relaxation intervention for patients with advanced lung cancer: a qualitative feasibility study. Scand J Med Sci Sports 2012, 22:804-815.
34. Andersen A.H., Vinther A., Poulsen L.L., Mellemgaard A. Do patients with lung cancer benefit from physical exercise?. Acta Oncol 2011, 50:307-313.
35. Quist M., Rørth M., Langer S., Jones L.W., Laursen J.H., Pappot H., et al. Safety and feasibility of a combined exercise intervention for inoperable lung cancer patients undergoing chemotherapy: a pilot study. Lung Cancer 2012, 75:203-208.
36. Cheville A.L., Kollasch J., Vandenberg J., Shen T., Grothey A., Gamble G., et al. A home-based exercise program to improve function, fatigue, and sleep quality in patients with Stage IV lung and colorectal cancer: a randomized controlled trial. J Pain Symptom Manage 2013, 45:811-821.
37. Jones L.W., Eves N.D., Mackey J.R., Peddle C.J., Haykowsky M., Joy A.A., et al. Safety and feasibility of cardiopulmonary exercise testing in patients with advanced cancer. Lung Cancer 2007, 55:225-232.
38. Hwang C.L., Yu C.J., Shih J.Y., Yang P.C., Wu Y.T. Effects of exercise training on exercise capacity in patients with non-small cell lung cancer receiving targeted therapy. Support Care Cancer 2012, 20:3169-3177.
39. Temel J.S., Greer J.A., Goldberg S., Vogel P.D., Sullivan M., Pirl W.F., et al. A structured exercise program for patients with advanced non-small cell lung cancer. J Thorac Oncol 2009, 4:595-601.
40. Barton R., English A., Nabb S., Rigby A.S., Johnson M.J. A randomised trial of high versus low intensity training in breathing techniques for breathless patients with malignant lung disease: a feasibility study. Lung Cancer 2010, 70:313-319.
41. Ozalevli S., Ilgin D., KulKaraali H., Bulac S., Akkoclu A. The effect of in-patient chest physiotherapy in lung cancer patients. Support Care Cancer 2010, 18:351-358.
42. Zhao I., Yates P. Non-pharmacological interventions for breathlessness management in patients with lung cancer: a systematic review. Palliat Med 2008, 22:693-701.
43. Garber C.E., Blissmer B., Deschenes M.R., Lamonte M.J., Lee I.M., Nieman D.C., et al. American College of Sports Medicine. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc 2011, 43:1334-1359.
44. Borg G. Borg's Perceived Exertion and Pain Scales 1998, Human Kinetics, Champaign, IL.
45. Froböse I., Lagerstrøm D. Muskeltraining in Prävention und Rehabilitation nach modernen trainingswissenschaftlichen Prinzipien, Teil 1 u. 2. Gesundheitssport Sporttherapie 1991, 1:12-13. [2:9-11].
46. Schwan U. Krafttraining in der kardiologischen Sporttherapie. Bewegungstherapie Gesundheitssport 2010, 26:104-107.
47. Craig C.L., Marshall A.L., Sjöström M., Bauman A.E., Booth M.L., Ainsworth B.E., et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003, 35:1381-1395.
48. Aaronson N.K., Ahmedzai S., Bergman B., Bullinger M., Cull A., Duez N.J., et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993, 85:365-376.
49. Portenoy R.K., Thaler H.T., Kornblith A.B., Lepore J.M., Friedlander-Klar H., Kiyasu E., et al. The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer 1994, 30:1326-1336.
50. WHO Exercise Tests in Relation to Cardiovascular Function. Technic Report Series No. 338 1968, WHO, Geneva.
51. Malavolti M., Pietrobelli A., Dugoni M., Poli M., Romagndi E., De Critofaro P, et al. A new device for measuring daily total energy expenditure in free living individuals. Int J Body Compos Res 2005, 85:3-63.
52. Patel S.A., Slivka W.A., Sciurba F.C. Validation of a Wearable Body Monitoring Device in COPD. Am J Respir Crit Care Med 2004, 30:A771.
53. Borm G.F., Fransen J., Lemmens W.A. A simple sample size formula for analysis of covariance in randomized clinical trials. J Clin Epidemiol 2007, 60:1234-1238.
54. Cohen J. Statistical Power Analysis for the Behavioral Sciences, 2. Aufl 1988, Lawrence Erlbaum Associates, Hillsdale.
55. Courneya K.S., Segal R.J., Mackey J.R., Gelmon K., Reid R.D., Friedenreich C.M., et al. Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized trial. J Clin Oncol 2007, 25:4396-4404.
56. Segal R.J., Reid R.D., Courneya K.S., Sigal R.J., Kenny G.P., Prud'Homme D.G., et al. Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer. J Clin Oncol 2009, 27:344-351.
57. Jones L.W., Eves N.D., Haykowsky M., Joy A.A., Douglas P.S. Cardiorespiratory exercise testing in clinical oncology research: systematic review and practice recommendations. Lancet Oncol 2008, 9:757-765.
58. Cramp F., James A., Lambert J. The effects of resistance training on quality of life in cancer: a systematic literature review and meta-analysis. Support Care Cancer 2010, 18:1367-1376.
59. 2peak and the capillary supply to skeletal muscle. J Appl Physiol 1997, 82:1305-1310.
60. 2max in older men. J Appl Physiol 1990, 68:329-333.